Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

被引：2
|
作者：
Coombes, Ian D. [1 ,2 ,3 ]
Legg, Amy [1 ,3 ,4 ,6 ]
Patterson, Tina [3 ,5 ,6 ]
Kelly, Tanya [3 ,7 ,8 ]
Henderson, Andrew [3 ,5 ,9 ]
Roberts, Jason A. [1 ,3 ,4 ,10 ,11 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
[2] Univ Queensland, Dept Pharm, Brisbane, Qld, Australia
[3] COVID 19 Med Pharm Planning & Response Grp, Brisbane, Qld, Australia
[4] Metro North Hlth, Herston Infect Dis Inst HeIDI, Brisbane, Qld, Australia
[5] COVID 19 Clin Therapeut Guideline Working Grp, Brisbane, Qld, Australia
[6] Logan Hosp, Dept Pharm, Brisbane, Qld, Australia
[7] Sunshine Coast Univ Hosp, Dept Anaesthesia & Perioperat Med, Sunshine Coast, Qld, Australia
[8] Queensland Clin Senate, Clin Excellence Queensland, Brisbane, Qld, Australia
[9] Princess Alexandra Hosp, Dept Infect Dis, Brisbane, Qld, Australia
[10] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia
[11] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
来源：
AUSTRALIAN PRESCRIBER | 2022年 / 45卷 / 02期
关键词：
COVID-19; molnupiravir; nirmatrelvir/ritonavir; quality use of medicines; SARS-CoV-2;
D O I：
10.18773/austprescr.2022.021
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [31] Real-world effectiveness of oral antivirals for COVID-19
    Burdet, Charles
    Ader, Florence
    [J]. LANCET, 2022, 400 (10359): : 1175 - 1176
  • [32] Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19
    Ratnakumar, Sharenja
    Denniston, Poppy
    Elliott, Michael
    Nair, Darshana
    West, Alex
    Mak, Szeman
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Treatment of COVID-19 Patients with mild or moderate Disease
    Lichert, Frank
    [J]. PNEUMOLOGIE, 2021, 75 (03): : 174 - 174
  • [34] Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
    Dougan, M.
    Nirula, A.
    Azizad, M.
    Mocherla, B.
    Gottlieb, R. L.
    Chen, P.
    Hebert, C.
    Perry, R.
    Boscia, J.
    Heller, B.
    Morris, J.
    Crystal, C.
    Igbinadolor, A.
    Huhn, G.
    Cardona, J.
    Shawa, I
    Kumar, P.
    Adams, A. C.
    Van Naarden, J.
    Custer, K. L.
    Durante, M.
    Oakley, G.
    Schade, A. E.
    Holzer, T. R.
    Ebert, P. J.
    Higgs, R. E.
    Kallewaard, N. L.
    Sabo, J.
    Patel, D. R.
    Dabora, M. C.
    Klekotka, P.
    Shen, L.
    Skovronsky, D. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1382 - 1392
  • [35] Kidney outcome after mild to moderate COVID-19
    Schmidt-Lauber, Christian
    Haenzelmann, Sonja
    Schunk, Stefan
    Petersen, Elina L.
    Alabdo, Ammar
    Lindenmeyer, Maja
    Hausmann, Fabian
    Kuta, Piotr
    Renne, Thomas
    Twerenbold, Raphael
    Zeller, Tanja
    Blankenberg, Stefan
    Fliser, Danilo
    Huber, Tobias B.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (09) : 2031 - 2040
  • [36] Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19
    Malani, Preeti N.
    Golub, Robert M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 644 - 645
  • [37] New Antiviral on the Horizon for Mild to Moderate COVID-19
    Harris, Emily
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10): : 821
  • [38] Neurological manifestations in mild and moderate cases of COVID-19
    Azim, Ghada Saed Abdel
    Osman, Marwa Abdellah
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [39] Neurological manifestations in mild and moderate cases of COVID-19
    Ghada Saed Abdel Azim
    Marwa Abdellah Osman
    [J]. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [40] Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment
    Gomaa, Adel A.
    Abdel-Wadood, Yasmin A.
    Gomaa, Mohamed A.
    [J]. INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 1977 - 1992
12345